Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced the presentation of preclinical data on CID-078 at the ...

BridgeBio Pharma, Inc.'s stock soars on Attruby's launch and licensing deals. Click for more on BBIO growth, competition, and ...

The product is then released from the enzyme, which can then bind to another substrate and repeat the process. Biocatalysis is widely used in the pharmaceutical industry to make small molecule drugs, ...

Cell division is an essential biological process that removes aged cells and continuously renews tissues. In the human body, billions of cells divide each day: intestinal cells are completely renewed ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced seven upcoming poster presentations at the 2025 American Society of ...

A substance developed at UC San Diego improved coral larvae settlement by up to 20 times in experiments compared to untreated ...

With coral reefs in crisis due to climate change, scientists have engineered a bio-ink that could help promote coral larvae settlement and restore these underwater ecosystems before it's too late.

X, engineered by California scientists promotes coral larvae populations to restore threatened ocean ecosystems.

Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.

More studies are needed to prove that the gel can work with other corals. Read more at straitstimes.com. Read more at ...

Endangered coral reefs could be saved by a special ink, according to new research. The bio-ink, called SNAP-X, was engineered ...